%0 Journal Article
%T Economics of gastroenteropancreatic neuroendocrine tumors: a systematic review
%A Beatriz Bern¨¢rdez
%A Carlos L¨®pez
%A Enrique Grande
%A Jaume Capdevila
%A Javier Aller
%A Javier Munarriz
%A Juan-Jos¨¦ Reina
%A Marta Trapero-Bertran
%A Paula Jimenez Fonseca
%A Rocio Garcia-Carbonero
%A Ruth Vera
%A ¨¢ngel D¨ªaz
%J Archive of "Therapeutic Advances in Endocrinology and Metabolism".
%D 2019
%R 10.1177/2042018819828217
%X Despite current interest, enthusiasm and progress in the development of therapies for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs), there are substantial gaps in the published literature regarding cost-of-illness analyses, economic evaluation and budget impact analyses. Compounding the issue is that data on resource utilization and cost-effectiveness of different diagnostic and therapeutic modalities for GEP-NETs are scarce
%K budget impact
%K cost-of-illness
%K costs
%K economic burden
%K economic evaluation
%K gastroenteropancreatic neuroendocrine tumors
%K resource utilization
%K systematic review
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381439/